Evidence map›Paper›PMID 35892927›Full record

ArticleBiotech (Basel (Switzerland))2022

Screening and Characterization of

Asma Azmani, Sanaa Lemriss, Mustapha Barakate, Amal Souiri, Driss Dhiba, Lahcen Hassani, Hanane Hamdali

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biotech (Basel (Switzerland)), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Revealing Genome-Based Biosynthetic Potential ofAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Asma AzmaniLaboratory of Agro-Industrial and Medical Biotechnologies, Faculty of Sciences and Technology, University of Sultan Moulay Slimane, P.O. Box 523, Beni-Mellal 23000, Morocco.
Sanaa LemrissLaboratory of Agro-Industrial and Medical Biotechnologies, Faculty of Sciences and Technology, University of Sultan Moulay Slimane, P.O. Box 523, Beni-Mellal 23000, Morocco.ORCID 0000-0001-5183-6148
Mustapha BarakateCadi Ayyad University, Faculty of Sciences Semlalia, Laboratory of Microbial Biotechnologies Agrosciences and Environment (BioMAgE, Labelled Unit CNRST N°4), P.O. Box 2390, Marrakech 40000, Morocco.ORCID 0000-0002-6276-9523
Amal SouiriLaboratory of Agro-Industrial and Medical Biotechnologies, Faculty of Sciences and Technology, University of Sultan Moulay Slimane, P.O. Box 523, Beni-Mellal 23000, Morocco.ORCID 0000-0002-7363-8991
Driss DhibaUniversity Mohammed 6 Polytechnic (UM6P), International Water Research Institute (IWRI), Moulay Rachid, Ben Guerir 43150, Morocco.ORCID 0000-0001-8431-9649
Lahcen HassaniCadi Ayyad University, Faculty of Sciences Semlalia, Laboratory of Microbial Biotechnologies Agrosciences and Environment (BioMAgE, Labelled Unit CNRST N°4), P.O. Box 2390, Marrakech 40000, Morocco.
Hanane HamdaliLaboratory of Agro-Industrial and Medical Biotechnologies, Faculty of Sciences and Technology, University of Sultan Moulay Slimane, P.O. Box 523, Beni-Mellal 23000, Morocco.ORCID 0000-0002-9222-2393
Université Sultan Moulay Slimane · MACadi Ayyad University · MAUniversité Mohammed VI Polytechnique · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional antimicrobial antibiotics are increasingly suffering from the emergence of multidrug resistance among pathogenic microorganisms. The antibiotic era is threatened by the ruthless rise of resistance in bacterial infections. A significant role in these resistance profiles is attributed to multidrug efflux pumps. Hence, much effort is being directed towards developing new compounds to overcome this problem. During our screening program of efflux pumps inhibitors (EPI) produced by bioactive Moroccan Actinobacteria, 210 isolates were screened for their antibacterial activities against

Indexed as

efflux pumps inhibitormolecular identificationscreeningStreptomyces

Identifiers

PMID35892927
PMCPMC9326602
OpenAlexW4283731522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.